Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $13.58M | $0.26 | $10.00 | 3,687.88% | Strong Buy | 2 | N/A | N/A | -27,082.36% | -387.16% | |||
| KALA | KALA BIO INC | $7.39M | $0.90 | $32.67 | 3,529.67% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| CANF | CAN-FITE BIOPHARMA LTD | $3.69M | $0.31 | $6.75 | 2,077.42% | Strong Buy | 2 | 209.62% | N/A | 0.00% | 0.00% | |||
| ACET | ADICET BIO INC | $81.84M | $0.53 | $8.50 | 1,491.76% | Strong Buy | 2 | N/A | N/A | -39.39% | -30.60% | |||
| NRXP | NRX PHARMACEUTICALS INC | $66.31M | $2.36 | $36.50 | 1,446.61% | Strong Buy | 4 | 1,164.95% | N/A | -556.39% | 955.57% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $166.90M | $0.50 | $7.00 | 1,311.29% | Buy | 3 | 52.10% | N/A | 842.99% | 59.37% | |||
| MBRX | MOLECULIN BIOTECH INC | $14.74M | $7.24 | $100.00 | 1,281.22% | Buy | 2 | N/A | N/A | N/A | -43.07% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $45.27M | $2.07 | $26.67 | 1,188.26% | Buy | 3 | 227.16% | N/A | N/A | -54.28% | |||
| TVRD | TVARDI THERAPEUTICS INC | $39.21M | $4.18 | $53.60 | 1,182.30% | Strong Buy | 5 | N/A | N/A | -102.26% | -73.03% | |||
| SKYE | SKYE BIOSCIENCE INC | $38.47M | $1.20 | $15.00 | 1,150.00% | Buy | 3 | N/A | N/A | -133.44% | -106.03% | |||
| LSTA | LISATA THERAPEUTICS INC | $17.38M | $1.97 | $23.50 | 1,092.89% | Strong Buy | 2 | 101.85% | N/A | -50.75% | -40.52% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $359.30M | $3.32 | $39.50 | 1,089.76% | Buy | 8 | N/A | N/A | -36.95% | -31.49% | |||
| PSTV | PLUS THERAPEUTICS INC | $89.33M | $0.65 | $7.25 | 1,015.38% | Strong Buy | 4 | 55.97% | N/A | -138.68% | -37.54% | |||
| GRI | GRI BIO INC | $6.73M | $2.06 | $22.50 | 992.23% | Buy | 2 | N/A | -80.86% | -59.63% | -24.85% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $14.10M | $1.31 | $14.00 | 968.70% | Buy | 2 | N/A | N/A | -51.33% | -43.90% | |||
| KRRO | KORRO BIO INC | $66.11M | $7.02 | $74.17 | 956.51% | Buy | 6 | -51.35% | N/A | -72.89% | -44.68% | |||
| VNRX | VOLITIONRX LTD | $36.84M | $0.30 | $3.17 | 955.67% | Strong Buy | 3 | 211.69% | N/A | -283.89% | 1,524.72% | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $42.61M | $0.87 | $9.00 | 934.48% | Strong Buy | 2 | N/A | N/A | -330.30% | -89.97% | |||
| CING | CINGULATE INC | $26.96M | $3.99 | $39.00 | 877.44% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| AKTX | AKARI THERAPEUTICS PLC | $24.23M | $0.34 | $3.30 | 873.45% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $67.61M | $1.92 | $18.50 | 863.54% | Strong Buy | 2 | N/A | N/A | -98.75% | -40.12% | |||
| IMUX | IMMUNIC INC | $79.99M | $0.67 | $6.33 | 852.33% | Strong Buy | 3 | N/A | N/A | -147.22% | -37.97% | |||
| IFRX | INFLARX NV | $71.81M | $1.06 | $10.00 | 843.40% | Buy | 3 | 202.47% | N/A | -69.43% | -48.34% | |||
| PMN | PROMIS NEUROSCIENCES INC | $17.03M | $7.91 | $71.50 | 803.92% | Strong Buy | 2 | N/A | N/A | -337.19% | -144.37% | |||
| SLN | SILENCE THERAPEUTICS PLC | $328.42M | $6.96 | $61.67 | 786.02% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| NAKA | KINDLY MD INC | $224.32M | $0.51 | $4.50 | 782.35% | Strong Buy | 2 | 386.36% | N/A | -1.88% | -1.30% | |||
| ONCY | ONCOLYTICS BIOTECH INC | $102.81M | $0.99 | $8.50 | 756.85% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $29.39M | $1.21 | $10.00 | 726.45% | Strong Buy | 2 | N/A | N/A | -133.24% | -111.24% | |||
| FEMY | FEMASYS INC | $51.46M | $0.88 | $7.25 | 723.86% | Strong Buy | 2 | 112.07% | N/A | -327.29% | -91.54% | |||
| CYBN | CYBIN INC | $137.97M | $5.99 | $49.33 | 723.59% | Strong Buy | 3 | N/A | N/A | -78.27% | -60.02% | |||
| ATYR | ATYR PHARMA INC | $80.74M | $0.82 | $6.33 | 668.57% | Buy | 3 | 549.70% | N/A | -17.23% | -12.96% | |||
| ZSPC | ZSPACE INC | $15.34M | $0.53 | $4.00 | 657.58% | Strong Buy | 2 | -5.46% | N/A | N/A | -178.34% | |||
| AMTX | AEMETIS INC | $99.66M | $1.52 | $11.50 | 656.58% | Strong Buy | 2 | 62.48% | N/A | -21.94% | 27.74% | |||
| MYO | MYOMO INC | $39.97M | $1.04 | $7.67 | 637.21% | Buy | 3 | 11.05% | N/A | 18.58% | 7.97% | |||
| CTSO | CYTOSORBENTS CORP | $45.85M | $0.73 | $5.38 | 636.30% | Buy | 2 | 26.52% | N/A | N/A | N/A | |||
| HUMA | HUMACYTE INC | $230.34M | $1.23 | $8.67 | 604.63% | Strong Buy | 6 | 277.66% | N/A | -8,282.35% | 430.01% | |||
| IBRX | IMMUNITYBIO INC | $2.26B | $2.29 | $16.00 | 598.69% | Strong Buy | 2 | 84.00% | N/A | -70.90% | 71.63% | |||
| BMEA | BIOMEA FUSION INC | $86.26M | $1.22 | $8.25 | 576.23% | Strong Buy | 4 | N/A | N/A | -503.29% | -142.44% | |||
| JSPR | JASPER THERAPEUTICS INC | $47.85M | $1.71 | $11.43 | 568.36% | Buy | 7 | N/A | N/A | -416.07% | -83.77% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $193.20M | $1.59 | $10.50 | 560.38% | Strong Buy | 2 | 111.86% | N/A | N/A | -574.54% | |||
| NKTX | NKARTA INC | $127.85M | $1.80 | $11.67 | 548.17% | Strong Buy | 3 | N/A | N/A | -33.23% | -26.28% | |||
| ZYXI | ZYNEX INC | $27.05M | $0.89 | $5.50 | 517.98% | Buy | 2 | 3.82% | N/A | N/A | -19.15% | |||
| TCRX | TSCAN THERAPEUTICS INC | $61.29M | $1.08 | $6.50 | 501.85% | Buy | 2 | 22.33% | N/A | -36.77% | -20.20% | |||
| CODX | CO-DIAGNOSTICS INC | $22.77M | $0.37 | $2.25 | 501.60% | Strong Buy | 2 | 201.95% | N/A | 73.29% | 65.25% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.